DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Long Term Provisions History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Long Term Provisions | ₹20 Cr | ₹26 Cr | ₹51 Cr | ₹75 Cr | ₹79 Cr |
What is the latest Long Term Provisions ratio of DR REDDYS LABORATORIES ?
Year | Long Term Provisions |
---|---|
Mar2023 | ₹20 Cr |
Mar2022 | ₹26 Cr |
Mar2021 | ₹51 Cr |
Mar2020 | ₹75 Cr |
Mar2019 | ₹79 Cr |
How is Long Term Provisions of DR REDDYS LABORATORIES Trending?
Years | Long Term Provisions | % Change | |
---|---|---|---|
Mar2023 | ₹20 Cr | -22.87 | |
Mar2022 | ₹26 Cr | -49.21 | |
Mar2021 | ₹51 Cr | -31.81 | |
Mar2020 | ₹75 Cr | -6.05 | |
Mar2019 | ₹79 Cr | - |
Compare Long Term Provisions of peers of DR REDDYS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DR REDDYS LABORATORIES | ₹104,975.6 Cr | 5.7% | 2.7% | 29.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹365,167.0 Cr | 2.6% | -4.7% | 54.7% | Stock Analytics | |
CIPLA | ₹113,645.0 Cr | 4.4% | -4.4% | 54.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,890.0 Cr | 5.8% | 17.7% | 24.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,950.6 Cr | 0.4% | -5.4% | 82.7% | Stock Analytics | |
MANKIND PHARMA | ₹95,492.3 Cr | -0.4% | 6% | NA | Stock Analytics |
DR REDDYS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DR REDDYS LABORATORIES | 5.7% |
2.7% |
29.3% |
SENSEX | 1.4% |
2.5% |
24.3% |
You may also like the below Video Courses